Suven Pharmaceuticals Ltd.

NSE: SUVENPHAR | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
1053.2500 -34.75 (-3.19%)
NSE Apr 07, 2025 15:31 PM
Volume: 197.6K
 

1053.25
-3.19%
ICICI Securities Limited
Suven is currently on a three pronged investment plan, 1) Relocating R&D centre, 2) Replacement and upgradation of blocks at Suryapet facility and 3) Additional new block in line with FDA regulations at Pashamylaram facility...
Number of FII/FPI investors increased from 181 to 201 in Dec 2024 qtr.
More from Suven Pharmaceuticals Ltd.
Recommended